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WE have analysed the relationship of blood eosi-
nophil count and serum eosinophil cationic
protein (ECP) levels in patients with acute and
chronic idiopathic urticaria. The ECP levels and
eosinophil counts were measured in the periph-
eral blood of 15 patients with acute urticaria, 25
with chronic idiopathic urticaria and 10 normal
healthy subjects. Blood eosinophil counts and
serum ECP levels increased in all patients with
acute urticaria. Concerning patients affected by
chronic urticaria, taking into account the recru-
descence of the disease at the moment of taking
the blood sample, only symptomatic patients
showed increased eosinophil blood values
whereas serum ECP levels were increased both in
symptomatic and asymptomatic patients. Further-
more, serum ECP levels in chronic urticaria did
not correlate with the peripheral eosinophil
counts, as they did in acute urticaria. The results
of the present study indicate that eosinophils
may play a role in the inflammatory mechanisms
in patients with acute and chronic urticaria
showing a positive correlation between serum
ECP levels and disease activity.
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Introduction
Circumscribed, raised, erythematous, evanes-
cent areas (weals) of oedema that involve the
superficial portions of the dermis are known as
urticaria. Recurrent episodes of urticaria, charac-
terized by transitory itchy weals, lasting longer
than 8 to 12 weeks, are termed chronic. Many
cases of acute urticaria are triggered by IgE anti-
bodies to various foods, drugs, inhalants, or
other allergens.
2 There is a strong consensus that
it is rarely possible to demonstrate IgE antibodies
as a cause of chronic urticaria, although in this
case autoantibodies against the high-affinity IgE
receptor may be involved.
In chronic urticaria, previous studies have
demonstrated that an increased number of mast
cells, monocytes, T-lymphocytes and eosinophils
are present in biopsy specimens.
4-7 Yet the role
played by eosinophils in the pathogenesis of skin
lesions is not completely understood. The acti-
vated eosinophil itself elaborates a variety of
inflammatory mediators, including, leukotrienes,
the major basic protein, eosinophil cationic
protein (ECP), the eosinophil protein X/eosino-
phil-derived neurotoxin and eosinophil peroxi-
dase.
8 The elaboration of these different
mediators is consistent with the hypothesis that
the eosinophil can be involved in both-allergic
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and nonallergic mechanisms. Particularly, ECP
may affect neurogenic responses and might there-
fore play a role in itching conditions. Previous
studies have provided evidence that ECP may
mediate cutaneous tissue damage and, in particu-
lar, be involved in chronic idiopathic urticaria.9-1
Samples from local venous blood in cold urticaria
have shown raised levels of histamine and eosino-
phil chemotactic factor.
14 To gain insight intc the
role of eosinophils in chronic urticaria, we have
analysed the relationship of eosinophils to serum
ECP levels in patients with acute and chronic idio-
pathic urticaria.
Patients and Methods
Patients: Fifteen patients with acute urticaria and
25 patients with chronic idiopathic urticaria took
part in the study. Acute and chronic urticaria
were respectively defined as weals lasting less
than 24 h and as recurrent weals lasting at least 6
weeks or more than 2 months (median 100
weeks). Patients affected by chronic urticaria
were split in two groups, taking into account the
recrudescence of the disease, at the moment of
taking the blood sample. Thirteen patients were
symptomatic with daily eruptions, whereas 12
patients were asymptomatic for at least 3 weeks.
Patients with urticaria, resulting predominantly
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Table 1. Eosinophil blood counts (mean -I- S.D.)in healthy
subjects and in patients with acute or chronic urticaria
n Eosinophils x 103/pl
Healthy subjects 10 O. 190 -I- 0.045
Acute urticaria 15 0.513 +__ 0.21 lb
Chronic urticaria 25 0.230 +__ 0.090
Chronic urticaria 13 0.270 +__ 0.090
(symptomatic)
Chronic urticaria 12 0.186 + 0.069
(asymptomatic)
vs. b p 0.001 b vs. c p 0.0001
vs. c p N.S. b vs. d p 0.001
vs. dp=O.01 b vs. ep=0.002
vs. ep= N.S. d vs. ep=0.01
Table 2. Serum ECP values (mean _+ S.D.) in healthy subjects
and in patients with acute or chronic urticaria
n ECP (lg/I)
Healthy subjects 10 4.04 ___
0.84
Acute urticaria 15 35.84 + 17.25
Chronic urticaria 25 25.28 ___
16.08
Chronic urticaria 13 37.77 + 12.60
(symptomatic)
Chronic urticaria 12 11.75 + 2.68
(asymptomatic)
vs. b p 0.0001 b vs. c p N.S.
vs. cp=O.O001 b vs. dp=N.S.
vs. d p 0.0001 b vs. e p 0.0001
vs. e p 0.001 d vs. e p 0.0001
from physical causes were excluded. Anti-
histamine treatment was stopped at least 48h
before the serum samples were collected. None
of the patients was taking steroids or immuno-
suppressive drugs at the time of the study. The
control group consisted of ten healthy members
of the laboratory staff without urticaria or a
history of atopy. All the subjects examined were
women. Informed consent was obtained from all
participants.
Eosinophil blood count.. A venous blood sample
was collected, and the eosinophils were counted
in a Fuchs Rosenthal chamber after staining with
eosinophil staining solution.5
Quantification of ECP: The blood samples were
stored for i h at room temperature before cen-
trifugation at 1600 x g at 4C for 10min. Serum
was collected and recentrifuged at 1600 x g at
4C for 10 min. The collected samples were
stored at-70C until assay. A double antibody
radioimmunoassay test has been used to quantify
serum ECP. The assay was performed with com-
mercially available kits purchased from Pharmacia
Diagnostics (Uppsala, Sweden), according to
manufacturers’ instructions. The intra-assay coef-
ficient of variation was less than 70%, and the
detection limit was less than 2 I.tg/1.
Statistical analysis: All data are expressed as
means + S.D. Correlations were calculated by
linear regression. The values for the different
group were compared with Student’s t-test.
Results
Table 1 shows mean values of the eosinophil
blood counts from the ten normal healthy sub-
jects, the 15 patients with acute urticaria and the
25 patients with chronic urticaria. The mean eos-
inophil counts were significantly higher both in
patients with acute urticaria and in patients with
chronic symptomatic urticaria compared to that
of the healthy subjects. Patients affected by acute
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urticaria showed eosinophil count values signifi-
cantly higher than patients affected by chronic
urticaria. No significant difference was found
between the healthy subjects and the patients
with asymptomatic chronic urticaria.
Diversely, the mean ECP serum concentrations
were significantly higher both in patients with
acute urticaria and in patients with chronic urti-
caria compared to that of the healthy subjects; but
patients affected by acute urticaria did not show
ECP serum concentrations higher than patients
affected by chronic urticaria. Taking into account
the recrudescence of the chronic urticaria, signifi-
cant differences were found between the healthy
subjects and both symptomatic and asymptomatic
patients. Finally, in the asymptomatic chronic
patients mean ECP serum concentrations were
significantly lower than both in patients affected
by acute urticaria and in patients affected by
chronic symptomatic urticaria (Table 2).
Eosinophil blood counts and ECP serum con-
centrations demonstrated a significant positive
correlation in patients with acute urticaria
(Fig. 1A), whereas eosinophil blood counts and
ECP serum concentrations were not related in
patients with chronic urticaria analysed either on
the whole (Fig. 1B) or on the basis of the recru-
descence or not of the disease (data not shown).
Discussion
The aim of the present study was to investigate
the relationships between the blood eosinophil
counts and serum ECP levels in patients with
acute and chronic urticaria. Blood eosinophil
counts and serum ECP levels increased in all
patients with acute urticaria. Concerning patients
affected by chronic urticaria, taking into account
the recrudescence of the disease at the moment
of taking the blood sample, only symptomatic
patients showed increased eosinophil blood
values whereas serum ECP levels were increased
both in symptomatic and asymptomatic patients.
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FIG. 1. (A) Correlation between serum ECP values (lg/I) and
eosinophil blood counts (x 103/ILtl) in 15 patients with acute
urticaria (r-- 0.73; p 0.0016). (B) Correlation between serum
ECP values (pg/I) and eosinophil blood counts (x 103/!al)in 25
patients with chronic urticaria (r 0.32; p N.S.).
caria did not correlate with the peripheral eos-
inophil counts, as they did in acute urticaria.
However these results indicate that eosinophils
may play a pathogenetic role in the inflammatory
mechanisms underlying both acute and chronic
urticaria.
What are the reasons for the elevated ECP
levels in these patients? In order to discuss this
question we have to understand the mechanism
behind the presence of ECP in serum. Serum
levels of ECP are dependent on three factors.
One is the number of eosinophils in the blood.
The second is the content of ECP of the eosino-
phil population and the third is the propensity of
1( the eosinophils to secrete their ECP. In acute
urticaria the ECP levels are completely paralleled
by blood eosinophil counts. This could be due
to a parallel change in the production of eosino-
phils in the bone marrow and in the activation
of the eosinophil population. In chronic urticaria
discrepancies between blood eosinophil counts
and serum ECP levels are found. In this case the
induction of eosinophil production and activation
are dissociated, as we have observed in asthma
patients treated with a long-acting fl2-agonist.v
In other words, some of the factors involved in
the induction and enhancement of eosinophilo-
poiesis process are not involved in the activation
process, and vice versa. Thus, depending on
the factors produced in the urticaria process, the
response of the eosinophil may vary. These varia-
tions in the response of the eosinophils probably
give rise to the different patterns of blood eos-
inophil counts and serum ECP levels. Our data
show a positive correlation between serum ECP
levels and disease activity and support the
concept that acute urticaria and chronic urticaria
may represent a spectrum of disease activity
rather than separate entities.
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